Metomylan

Metoprolol Tartrate, the active ingredient in Metomylan, is a beta blocker presented as an oral dosage form for oral use. It treats hypertension, angina, myocardial infarction, heart failure, and cardiac arrhythmias in adult patients.

GNH USA supplies Metomylan as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metoprolol Tartrate is used to manage cardiovascular conditions that involve elevated heart rate or excessive cardiac workload. - Hypertension: lowers blood pressure by reducing heart rate and cardiac output. - Angina pectoris: decreases myocardial oxygen demand, relieving chest pain. - Myocardial infarction: improves survival after a heart attack by limiting further cardiac stress. - Heart failure: reduces ventricular workload and improves symptoms. - Cardiac arrhythmias: controls abnormal heart rhythms by slowing conduction through the AV node.

Metoprolol Tartrate may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Fatigue or tiredness - Dizziness or light‑headedness - Bradycardia (slow heart rate) - Cold extremities or reduced peripheral circulation - Gastrointestinal upset (nausea, abdominal discomfort) - Depression or mood changes

Serious or Rare Side Effects: - Severe bradycardia or heart block - Marked hypotension - Bronchospasm, especially in patients with asthma or COPD - Acute heart failure exacerbation - Allergic reactions (rash, angioedema, anaphylaxis) - Cardiogenic shock

Before initiating Metoprolol Tartrate, clinicians should evaluate patient-specific factors and monitor therapy closely. - Cardiac assessment: verify baseline heart rate and blood pressure. - Respiratory caution: avoid in uncontrolled asthma or severe COPD. - Renal/hepatic function: adjust dose in impairment. - Concomitant drugs: review other beta‑blockers or calcium‑channel blockers. - Pregnancy: category C; weigh maternal benefits against fetal risks. - Store at below 25°C: keep in the original pack, protect from moisture.

Metoprolol Tartrate can interact with several medication classes; awareness of interaction severity guides clinical decisions.

Major Interactions (Avoid): - Other beta‑blockers: additive cardiac depression. - Non‑dihydropyridine calcium‑channel blockers (verapamil, diltiazem): risk of severe bradycardia and AV block. - Class I antiarrhythmics (e.g., quinidine): enhanced negative chronotropic effect. - MAO inhibitors: possible hypertensive crisis.

Moderate Interactions (Monitor Closely): - NSAIDs: may blunt antihypertensive effect. - Diuretics: increase risk of hypotension. - Antidiabetic agents: may mask hypoglycemia symptoms. - Antidepressants (SSRIs, SNRIs): potential for additive bradycardia. - Anesthetic agents: may potentiate cardiovascular depression.